Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx

News Daily News

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx

May 29, 2025

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

News Conference News EuroPCR 2025

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

May 28, 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

May 22, 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

News Features

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

May 19, 2025

Presentation Fellows 2025

Case and Technique Reviews: Management of Left Main and Multivessel Disease

Presenter: Jeffrey W. Moses

May 17, 2025

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Yael L. Maxwell

May 15, 2025

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

News Daily News

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

April 28, 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

News Conference News ACC 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Michael O'Riordan

April 04, 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

March 30, 2025

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

February 18, 2025

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

February 14, 2025

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

News Daily News

Intravascular Imaging During PCI Should Be a Performance Metric, Researchers Say

February 11, 2025

Lower Diagnostic Success With Transradial Cerebral Angiography

News Conference News ISC 2025

Lower Diagnostic Success With Transradial Cerebral Angiography

February 07, 2025

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.